<div class="container">

<table style="width: 100%;"><tr>
<td>E1690</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>ECOG E1690 Trial</h2>

<h3>Description</h3>

<p>A data set from the ECOG E1690 trial evaluating the effectiveness of the interferon alfa-2b
(IFN) therapy compared to the observation in high-risk melanoma patients. There were three
arms in the trial: high-dose IFN, low-dose IFN, and observation. The study results were
described in Kirkwood et al. (2000) <a href="doi:10.1200/JCO.2000.18.12.2444">doi:10.1200/JCO.2000.18.12.2444</a>. Here, we only consider
the high-dose IFN arm and the observation arm so that this data set has the same variables as
the E1684 data set. We can use the E1684 data as the historical data and the E1690 data as the
current data.
</p>


<h3>Usage</h3>

<pre><code class="language-R">E1690
</code></pre>


<h3>Format</h3>

<p>A data frame with 426 rows and 8 variables:
</p>

<dl>
<dt>failtime</dt>
<dd>
<p>time to relapse in years</p>
</dd>
<dt>failcens</dt>
<dd>
<p>censoring indicator for time to relapse, 0 = did not relapse, 1 = relapsed</p>
</dd>
<dt>survtime</dt>
<dd>
<p>time to death in years</p>
</dd>
<dt>survcens</dt>
<dd>
<p>censoring indicator for time to death, 0 = alive, 1 = dead</p>
</dd>
<dt>treatment</dt>
<dd>
<p>treatment indicator, 0 = observation, 1 = high-dose IFN</p>
</dd>
<dt>sex</dt>
<dd>
<p>gender indicator, 0 = male, 1 = female</p>
</dd>
<dt>age</dt>
<dd>
<p>patient age in years</p>
</dd>
<dt>node_bin</dt>
<dd>
<p>indicator for having more than one cancerous lymph node,
0 = with one or no cancerous lymph nodes,
1 = with more than one cancerous lymph node</p>
</dd>
</dl>
<h3>References</h3>

<p>Kirkwood, J. M., Ibrahim, J. G., Sondak, V. K., Richards, J., Flaherty, L. E., Ernstoff, M. S., Smith, T. J., Rao, U., Steele, M., and Blum, R. H. (2000). High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190. Journal of Clinical Oncology, 18(12), 2444â€“2458.
</p>


</div>